Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Gard

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
The Australian & New Zealand Journal of Obstetrics & Gynaecology|June 28, 2000
Referral patterns for gynaecological radiotherapy in VictoriaG B Gard, M A Quinn, K Narayan, et al.
Gynecologic Oncology|November 15, 2017
Combining serum microRNA and CA-125 as prognostic indicators of preoperative surgical outcome in women with high-grade serous ovarian cancerJaynish S Shah, Gregory B Gard, Jean Yang, et al.
Acta Medica Portuguesa|March 1, 1989
[Alcoholism in an industrial population: diagnosis, prevalence and conditioning factors]P Fidalgo, M P Alves, A Freire, et al.
BMC Cancer|January 1, 2013
Elevated levels of circulating microRNA-200 family members correlate with serous epithelial ovarian cancerCasina W S Kan, Michael A Hahn, Gregory B Gard, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 10, 2001
First reported case of endometrial carcinoma in association with HIV infectionG. B. Gard, O. M. McNally, N. J. Mulvany, et al.
Scientific Reports|May 19, 2016
Assessing mutant p53 in primary high-grade serous ovarian cancer using immunohistochemistry and massively parallel sequencingAlexander J Cole, Trisha Dwight, Anthony J Gill, et al.
Gynecologic Oncology|December 26, 2013
Dietary folate and related micronutrients, folate-metabolising genes, and ovarian cancer survivalS C Dixon, T I Ibiebele, M M Protani, et al.
Scientific Data|September 6, 2017
Comprehensive analyses of somatic TP53 mutation in tumors with variable mutant allele frequencyAlexander J Cole, Ying Zhu, Trisha Dwight, et al.
Human Molecular Genetics|November 1, 2016
The RING finger domain E3 ubiquitin ligases BRCA1 and the RNF20/RNF40 complex in global loss of the chromatin mark histone H2B monoubiquitination (H2Bub1) in cell line models and primary high-grade serous ovarian cancerKristie-Ann Dickson, Alexander J Cole, Anthony J Gill, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
The Australian & New Zealand Journal of Obstetrics & Gynaecology|June 28, 2000
Referral patterns for gynaecological radiotherapy in VictoriaG B Gard, M A Quinn, K Narayan, et al.
Gynecologic Oncology|November 15, 2017
Combining serum microRNA and CA-125 as prognostic indicators of preoperative surgical outcome in women with high-grade serous ovarian cancerJaynish S Shah, Gregory B Gard, Jean Yang, et al.
Acta Medica Portuguesa|March 1, 1989
[Alcoholism in an industrial population: diagnosis, prevalence and conditioning factors]P Fidalgo, M P Alves, A Freire, et al.
BMC Cancer|January 1, 2013
Elevated levels of circulating microRNA-200 family members correlate with serous epithelial ovarian cancerCasina W S Kan, Michael A Hahn, Gregory B Gard, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 10, 2001
First reported case of endometrial carcinoma in association with HIV infectionG. B. Gard, O. M. McNally, N. J. Mulvany, et al.
Scientific Reports|May 19, 2016
Assessing mutant p53 in primary high-grade serous ovarian cancer using immunohistochemistry and massively parallel sequencingAlexander J Cole, Trisha Dwight, Anthony J Gill, et al.
Gynecologic Oncology|December 26, 2013
Dietary folate and related micronutrients, folate-metabolising genes, and ovarian cancer survivalS C Dixon, T I Ibiebele, M M Protani, et al.
Scientific Data|September 6, 2017
Comprehensive analyses of somatic TP53 mutation in tumors with variable mutant allele frequencyAlexander J Cole, Ying Zhu, Trisha Dwight, et al.
Human Molecular Genetics|November 1, 2016
The RING finger domain E3 ubiquitin ligases BRCA1 and the RNF20/RNF40 complex in global loss of the chromatin mark histone H2B monoubiquitination (H2Bub1) in cell line models and primary high-grade serous ovarian cancerKristie-Ann Dickson, Alexander J Cole, Anthony J Gill, et al.
Pageof 2